Table 2

Treatment modalities and Outcomes of non metastatic patients
N. of patients (%)
Surgery 145
Radical mastectomy 104 72
Conservative surgery 41 28
Chemotherapy
Neoadjuvant chemotherapy 14 10
   pCR 4 28
Adjuvant chemotherapy 131 90
   Anthracycline based regimens 99 75
   Sequentiel anthracycline taxane 27 20
   Taxane alone 4 5
                Outcomes
Overall survival at 5 years 79,7
   Stade I 92,3
   Stade II 86,5
   Stade III 57,8
Disease free survival at 5 years 77,8

Rais et al.

Rais et al. BMC Women's Health 2012 12:35   doi:10.1186/1472-6874-12-35

Open Data